AI Insight
Researchers at the Helmholtz Institute for Pharmaceutical Research Saarland have identified five new classes of bioactive compounds from soil-dwelling myxobacteria. The study focuses on previously understudied bacterial species as sources for novel antibiotic development, since most current clinical antibiotics are derived from natural compounds produced by bacteria and microorganisms.
Why it matters
The discovery of new classes of bioactive compounds is critical for addressing antibiotic resistance and expanding therapeutic options. By exploring less-studied bacterial species, this research opens new avenues for drug development beyond conventional sources.
Understand the Science
Most antibiotics used clinically are based on natural compounds produced by bacteria and other microorganisms. At the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), researchers are using soil-dwelling myxobacteria as a source of new active ingredients. They are able to discover new active compounds primarily in bacteria that have not yet been extensively studied.
Source: Soil-dwelling myxobacteria reveal five new classes of bioactive compounds